Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthyinfants and toddlers in Spain
Javier Diez-Domingo, Alejandra Gurtman, Enrique Bernaola, Francisco Gimenez-Sanchez, Federico Martinon-Torres, Valentin Pineda-Solas, Alfonso Delgado, Pilar Infante-Marquez, John Z. Liang, Peter C. Giardina, William C. Gruber, Emilio A. Emini, Daniel A. Scott
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
THE NEVER ENDING STORY OF CORTICOSTEROIDS IN ACUTE BRONCHIOLITIS
Martinón-Torres F, Montero-Martín M.
Journal:
Pediatrics
Publicación independiente
Impact factor
5.359
Q1
Year:
2013
Doi:
Noninvasive ventilation with helium-oxygen in children
Federico Martinón Torres
Journal:
J. Crit Care
Publicación independiente
Impact factor
2.685
Q3
Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine Manufactured With Recombinant Human Albumin
Gabriela Rüger, Giovanni Gabutti, Hans Rümke, Lars Rombo, Enrique Bernaola, MD,|| Javier Diez-Domingo, Federico Martinon-Torres, Birthe Høgh, Antreas Konstantopoulos, Anne Fiquet, Stéphane Thomas, Cécile Eymin and Martine Baudin,
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q1
A reverse evidence of rotavirus vaccines impact.
Federico Martinón-Torres, Angela Aramburo, Nazareth Martinón-Torres, Miriam Cebey, María Teresa Seoane-Pillado, Lorenzo Redondo-Collazo and Jose Maria Martinón-Sánchez
Journal:
Human Vaccines & Immunother
Publicación independiente
Impact factor
2.619
Q2
Management of acute bronchiolitis in emergency wards in Spain: variability and appropriateness analysis (Abreviado project)
Ochoa Sangrador C, González de Dios J; Research Group of the aBREVIADo Project (Bronchiolitis--Study of Variability, Adequacy, and Adherence) (Martinón –Torres F).
Journal:
European J of Ped.
Publicación independiente
Impact factor
2.126
Q2
Year:
2012
Doi:
Pleural antigen assay in the diagnosis of pediatric pneumococcal empyema
Federico Martinón-Torres, Silvia Dosil-Gallardo, María Luisa Perez del Molino-Bernal, Fernanda Pardo Sánchez , David Tarrago, Fernando Alvez, Sonia Pertega Diaz, Nazareth Martinón-Torres, Jose Maria Martinon Sanchez
Journal:
J. Crit Care
Publicación independiente
Impact factor
2.685
Q3
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.
Richmond PC, Marshall HS, Nissen MD, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Beeslaar J, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Perez JL; 2001 Study Investigators.
Journal:
Lancet Infect Dis
Publicación independiente
Impact factor
24.446
Q1
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.
Gossger N, Snape MD, Yu LM, Finn A, Bona G, Esposito S, Principi N, Diez-Domingo J, Sokal E, Becker B, Kieninger D, Prymula R, Dull P, Ypma E, Toneatto D, Kimura A, Pollard AJ; European MenB Vaccine Study Group.
Journal:
JAMA
Publicación independiente
Impact factor
45.540
Q1
Year:
2012
Doi:
Acute gastroenteritis hospitalizations among children aged < 5 years before and after introduction of rotavirus vaccines: a hospital-based surveillance study in Galicia, Spain.
Federico Martinón-Torres, Nazareth Martinón-Torres, Marta Bouzón Alejandro, Lorenzo Redondo Collazo, Sonia Pértega-Díaz, María Teresa Seoane-Pillado, Jorge Aboal Viñas & María San-Martín
Journal:
Human Vaccines & Immunother
Publicación independiente
Impact factor
2.619
Q2
13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety.
Federico Martinón-Torres, Francisco Gimenez-Sanchez, Alejandra Gurtman, Enrique Bernaola, Javier Diez-Domingo, Alfonso Carmona, Mohinder Sidhu, Denise A. Sarkozy, William C. Gruber, Emilio A. Emini, and Daniel A. Scott, on behalf of the 3007 Study Group
Journal:
Pediatr Inf Dis J
Publicación independiente
Impact factor
2.126
Q2
Mechanical ventilation in pediatric intensive care units during the season for acute lower respiratory infection: a multicenter study.
Farias JA, Fernández A, Monteverde E, Flores JC, Baltodano A, Menchaca A, Poterala R, Pánico F, Johnson M, von Dessauer B, Donoso A, Zavala I, Zavala C, Troster E, Peña Y, Flamenco C, Almeida H, Nilda V, Esteban A; Latin-American Group for Mechanical Ventilation in Children (Martinón-Torres F).
Journal:
Pediatr Crit Care Med
Publicación independiente
Impact factor
2.854
Q1
Year:
2012
Doi:
Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine
Gimenez-Sanchez F, Kieninger DM, Kueper K, Martinon-Torres F, Bernaola E, Diez-Domingo J, Steul K, Juergens C, Gurtman A, Giardina P, Liang JZ, Gruber WC, Emini EA, Scott DA; 501 and 006 study groups.
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Vacuna universal frente a meningococo B
Carmen Rodríguez-Tenreiro, Federico Martinón-Torres
Journal:
An Pediatr Contin
Publicación independiente
Impact factor
1.313
Q4
Prospective evaluation of indirect costs due to acute rotavirus gastroenteritis in Spain: the ROTACOST study
Bouzón-Alejandro M, Redondo-Collazo L, Sánchez-Lastres JM, Martinón-Torres N, Martinón-Sánchez JM, Martinón-Torres F; ROTACOST research team
Journal:
BMC Pediatrics
Publicación independiente
Impact factor
1.909
Q2
Effectiveness of rotavirus vaccination in Spain.
Federico Martinón-Torres, Marta Bouzón Alejandro, Lorenzo Redondo Collazo, Juan Manuel Sánchez Lastres, Sonia Pértega Díaz, Mª Teresa Seoane Pillado & José María Martinón Sánchez
Journal:
Human Vaccines
Publicación independiente
Impact factor
2.619
Q2
Considerations on the clinical application of the human papillomavirus vaccine in Spain
Javier Cortés, Federico Martinon-Torres, José Manuel Ramón, Cajal, Gabriel Ferret and Angel Gil
Journal:
Human Vaccines
Publicación independiente
Impact factor
2.619
Q2
Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain
Marta Bouzón Alejandro, Javier Diez Domingo and Federico Martinón Torres
Journal:
Human Vaccines
Publicación independiente
Impact factor
2.619
Q2
Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study
Daniel H. Kett; Elie Azoulay; Pablo M. Echeverria; Jean-Louis Vincent; and for the Extended Prevalence of Infection in the ICU Study (EPIC II) Group of Investigators (F. Martinón-Torres)
Journal:
Crit Care Med.
Publicación independiente
Impact factor
7.414
Q1
Year:
2011
Doi:
Acute lung injury in children: Therapeutic practice and feasibility of international clinical trials
Santschi M, Jouvet P, Leclerc F, Gauvin F, Newth CJ, Carroll CL, Flori H, Tasker RC, Rimensberger PC, Randolph AG; for the PALIVE Investigators, the Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI); the European Society of Pediatric and Neonatal Intensive Care (ESPNIC) (Martinón-Torres F).
Journal:
Ped Crit Care Med
Publicación independiente
Impact factor
2.854
Q1
Year:
2010
Doi:
The Spanish human papillomavirus vaccine consensus group: A working model
Javier Cortés & Federico Martinón-Torres; Spanish HPV Vaccine Consensus Group.
Journal:
Human Vaccines
Publicación independiente
Impact factor
2.619
Q2
Multicenter prospective study analysing the role of rotavirus on acute gastroenteritis in Spain
Gimenez-Sanchez F, Delgado-Rubio A, Martinon-Torres F, Bernaola-Iturbe E; Rotascore Research Group.
Journal:
Acta Pediatr
Publicación independiente
Impact factor
2.111
Q1
Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease
Davila S, Wright VJ, Khor CC, Sim KS, Binder A, Breunis WB, Inwald D, Nadel S, Betts H, Carrol ED, de Groot R, Hermans PW, Hazelzet J, Emonts M, Lim CC, Kuijpers TW, Martinon-Torres F, Salas A, Zenz W, Levin M, Hibberd ML; International Meningococcal Genetics Consortium.
Journal:
Nature Genetics
Publicación independiente
Impact factor
27.603
Q1
Estudio de variabilidad en el abordaje de la bronquiolitis aguda en España en relación con la edad de los pacientes
J. González de Dios, C. Ochoa Sangrador, Grupo Investigador del Proyecto aBREVIADo (BRonquiolitis-Estudio de Variabilidad, Idoneidad, ADecuación) (F. Martinón-Torres)
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
Year:
2010
Doi:
No results found.
A NOVEL VACCINE TO PREVENT MENINGOCOCCAL DISEASE BEYOND THE FIRST YEAR OF LIFE: AN EARLY REVIEW OF MENACYW-TT
Martinón-Torres F, Bertrand-Gerentes I, Oster P
Doi:
Expert Rev Vaccines
Factor de impacto:
Q2
Doi:
A NICE COMBINATION FOR PREDICTING HOSPITALISATION AT THE EMERGENCY DEPARTMENT: A EUROPEAN MULTICENTRE OBSERVATIONAL STUDY OF FEBRILE CHILDREN
Borensztajn DM, Hagedoorn NN, Carrol ED, von Both U, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Lim E, Maconochie IK, Martinon-Torres F, Nieboer D, Nijman RG, Oostenbrink R, Pokorn M, Calle IR, Strle F, Tsolia M, Vermont CL, Yeung S, Zavadska D, Zenz W, Levin M, Moll HA; PERFORM consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union
Doi:
Lancet Reg Health Eur
Factor de impacto:
Q1
Doi:
DISTINCT PATTERNS OF WITHIN-HOST VIRUS POPULATIONS BETWEEN TWO SUBGROUPS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS
Lin GL, Drysdale SB, Snape MD, O'Connor D, Brown A, MacIntyre-Cockett G, Mellado-Gomez E, de Cesare M, Bonsall D, Ansari MA, Öner D, Aerssens J, Butler C, Bont L, Openshaw P, Martinón-Torres F, Nair H, Bowden R; RESCEU Investigators, Golubchik T, Pollard AJ
Doi:
Nat Commun
Factor de impacto:
Q1
Doi:
COADMINISTRATION OF ANTI-VIRAL MONOCLONAL ANTIBODIES WITH ROUTINE PEDIATRIC VACCINES AND IMPLICATIONS FOR NIRSEVIMAB USE: A WHITE PAPER
Esposito S, Abu-Raya B, Bonanni P, Cahn-Sellem F, Flanagan KL, Martinon Torres F, Mejias A, Nadel S, Safadi MAP, Simon A
Doi:
Front Immunol
Factor de impacto:
Q1
Doi:
AETIOLOGY OF ACUTE RESPIRATORY INFECTION IN PRESCHOOL CHILDREN REQUIRING HOSPITALISATION IN EUROPE-RESULTS FROM THE PED-MERMAIDS MULTICENTRE CASE-CONTROL STUDY
Kohns Vasconcelos M, Loens K, Sigfrid L, Iosifidis E, Epalza C, Donà D, Matheeussen V, Papachristou S, Roilides E, Gijon M, Rojo P, Minotti C, Da Dalt L, Islam S, Jarvis J, Syggelou A, Tsolia M, Nyirenda Nyang'wa M, Keers S, Renk H, Gemmel AL, D'Amore C, Ciofi Degli Atti M, Rodríguez-Tenreiro Sánchez C, Martinón-Torres F, Burokienė S, Goetghebuer T, Spoulou V, Riordan A, Calvo C, Gkentzi D, Hufnagel M, Openshaw PJ, de Jong MD, Koopmans M, Goossens H, Ieven M, Fraaij PLA, Giaquinto C, Bielicki JA, Horby P, Sharland M.
Doi:
BMJ Open Respir Res
Factor de impacto:
Q2
Doi:
A NOVEL FRAMEWORK FOR PHENOTYPING CHILDREN WITH SUSPECTED OR CONFIRMED INFECTION FOR FUTURE BIOMARKER STUDIES
Nijman RG, Oostenbrink R, Moll HA, Casals-Pascual C, von Both U, Cunnington A, De T, Eleftheriou I, Emonts M, Fink C, van der Flier M, de Groot R, Kaforou M, Kohlmaier B, Kuijpers TW, Lim E, Maconochie IK, Paulus S, Martinon-Torres F, Pokorn M, Romaine ST, Calle IR, Schlapbach LJ, Smit FJ, Tsolia M, Usuf E, Wright VJ, Yeung S, Zavadska D, Zenz W, Levin M, Herberg JA, Carrol ED; PERFORM consortium (Personalized Risk assessment in febrile children to optimize Real-life Management across the European Union).
Doi:
Front Pediatr
Factor de impacto:
Q1
Doi:
TRANSLATING MENINGOCOCCAL SEROGROUP B VACCINES FOR HEALTHCARE PROFESSIONALS
Safadi MAP, Martinón-Torres F, Serra L, Burman C, Presa J
Doi:
Expert Rev Vaccines
Factor de impacto:
Q2
Doi:
VENTRICULAR REPOLARIZATION PARAMETERS AND CORONARY INVOLVEMENT IN KAWASAKI DISEASE
Barrios-Tascón A, Miura M, Domínguez-Rodríguez S, Fernández-Cooke E, Sarquella-Brugada G, Tagarro A; KAWA-RACE study group, (Martinón-Torres F)
Doi:
J Pediatr
Factor de impacto:
Q1
Doi:
ROUTINE INFANT VACCINATION OF PNEUMOCOCCAL CONJUGATE VACCINES HAS DECREASED PNEUMONIA ACROSS ALL AGE GROUPS IN NORTHERN SPAIN
I. Rivero-Calle, J. Pardo Seco, P. F. Raguindin, F. Alvez, J. Gómez-Rial, A. Salas, J. Martinón Sanchez and F. Martinón-Torres
Hum Vaccine Immunother
Factor de impacto:
Q2
Doi:
QUADRIVALENT INFLUENZA VACCINE PREVENTS ILLNESS AND REDUCES HEALTHCARE UTILIZATION ACROSS DIVERSE GEOGRAPHIC REGIONS DURING FIVE INFLUENZA SEASONS. A RANDOMIZED CLINICAL TRIAL
Ghassan Dbaibo, Arshad Amanullah, Carine Claeys, Allen Izu, Varsha K. Jain, Pope Kosalaraksa, Luis Rivera, Jyoti Soni, Emad Yanni, Khalequ Zaman, Beatriz Acosta, Miguel Ariza, Maria L. Arroba Basanta, Ashish Bavdekar, Alfonso Carmona, Luis Cousin, Jasur Danier, Alfonso Diaz, Javier Diez-Domingo, Ener C. Dinleyici, Saul N. Faust, Jose Garcia-Sicilia, Grace D. Gomez-Go, Maria L. A. Gonzales, Mustafa Hacimustafaoglu, Stephen M. Hughes, Teresa Jackowska, Shashi Kant, Marilla Lucero, Josep Mares Bermudez, Federico Martinón-Torres, May Montellano, Roman Prymula, Thanyawee Puthanakit, Renata Ruzkova, Iwona Sadowska-Krawczenko Henryk Szymanski, Angels Ulied, Wayne Woo, Anne Schuind and Bruce L. Innis for the Flu4VEC Study Group
Pediatr Infect Dis J
Factor de impacto:
Doi: